Document Detail

Strained Ruthenium Complexes are Potent Light-Activated Anticancer Agents.
MedLine Citation:
PMID:  22553960     Owner:  NLM     Status:  Publisher    
Strained ruthenium complexes have been synthesized and characterized as novel agents for photodynamic therapy (PDT). The complexes are inert until triggered by visible light, which induces ligand loss and covalent modification of DNA. An increase in cytotoxicity of two orders of magnitude is observed with light activation in cancer cells, and the compounds display potencies superior to cisplatin against 3D tumor spheroids. The use of intramolecular strain may be applied as a general paradigm to develop light-activated ruthe-nium complexes for PDT applications.
Brock S Howerton; David Kayvon Heidary; Edith Caroline Glazer
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-3
Journal Detail:
Title:  Journal of the American Chemical Society     Volume:  -     ISSN:  1520-5126     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-4     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7503056     Medline TA:  J Am Chem Soc     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vaccine potential of cytosolic proteins loaded fibrin microspheres of Cryptococcus neoformans in BAL...
Next Document:  Advanced Solid-state NMR Characterization of Marine Dissolved Organic Matter Isolated Using the Coup...